4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-045394
Chief Legal Officer sold 6,576 shares at $6.74 ($44,322)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Mark Chief Legal Officer | 2025-03-25 | Sale 10b5-1 | −6,576 | $6.74 | $44,322 | 316,621 | D |
| Open-market sales · 6,576 sh · avg $6.74 · $44,322 | |||||||
Loading xslF345X05/ownership.xml…